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Abstract
Background: Visceral leishmaniasis has now emerged as an important opportunistic disease in patients coinfected with
human immunodeficiency virus type-1 (HIV-1). Although the effectiveness of HIV-1 protease inhibitors, such as nelfinavir, in
antiretroviral therapies is well documented, little is known of the impact of these drugs on Leishmania in coinfected
individuals.
Methodology and Principal Findings: Here, we show that nelfinavir generates oxidative stress in the parasite, leading to
altered physiological parameters such as an increase in the sub-G1 DNA content, nuclear DNA fragmentation and loss of
mitochondrial potential, which are all characteristics of apoptosis. Pretreatment of axenic amastigotes with the caspase
inhibitor z-VAD-fmk did not inhibit the increase in sub-G1 DNA content in nelfinavir-treated parasites, suggesting therefore
that this antiviral agent does not kill Leishmania amastigotes in a caspase-dependent manner. Furthermore, we observed
that the mitochondrial resident protein endonuclease G is involved. We also demonstrate that parasites overexpressing
GSH1 (the rate limiting enzyme of glutathione biosynthesis) were more resistant to nelfinavir when compared to
untransfected controls.
Conclusions and Significance: These data suggest that nelfinavir induces oxidative stress in Leishmania amastigotes,
culminating in caspase-independent apoptosis, in which DNA is degraded by endonuclease G. This study provides a
rationale for future, long-term design of new therapeutic strategies to test nelfinavir as a potential antileishmanial agent as
well as for possible future use in Leishmania/HIV-1 coinfections.
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Introduction
Leishmania is a family of zoonotic protozoan parasites that cause
a variety of human diseases termed leishmaniases, which have a
current annual incidence of 2 million new cases in 88 countries.
Depending on the species involved, infections in humans may lead
to a broad spectrum of clinical manifestations, ranging from
ulcerous skin lesions to more serious and potentially fatal visceral
diseases. Mobile, flagellate Leishmania promastigotes propagate in
the sand fly vector, and eventually differentiate into non dividing
metacyclic forms before inoculation into the vertebrate host and
phagocytosis by macrophages. The metacyclics subsequently
differentiate into amastigotes, which multiply in an intracellular
vacuolar compartment, leading to macrophage lysis and serial
infection of other surrounding macrophages. Besides being a
major tropical disease, leishmaniasis, and particularly visceral
leishmaniasis (VL) which is caused primarily by Leishmania infantum
(L. infantum) and L. donovani, is now also emerging as an important
opportunistic disease found in patients infected with human
immunodeficiency virus type-1 (HIV-1) [1]. Indeed, reactivation
of latent Leishmania infections have been reported to occur
frequently in HIV-1-infected and immunocompromised individ-
uals [2,3], and, on the other hand, the parasite is able to potentiate
and up-regulate virus replication, at least in vitro [4,5].
The recent development of highly active antiretroviral therapy
(HAART) has significantly improved the prognosis of patients
infected with HIV-1. This therapeutic strategy consists of at least
three anti-retroviral drugs, typically two nucleoside or nucleotide
reverse transcriptase inhibitors (NRTIs) used in combination with
a non-nucleoside reverse transcriptase inhibitor (NNRTI) or a
protease inhibitor (PI). It has been demonstrated that PIs block the
active site of aspartyl protease, a viral enzyme known to be
essential for the maturation of viral proteins, by mimicking
peptides [6]. In patients co-infected with Leishmania and HIV-1,
HAART is initiated to partially restore immune functions and it
has also been found to prevent VL in individuals infected by
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of VL in Europe following the widespread use of HAART [8,9].
Recently, two HIV-1 PIs (i.e. indinavir/IDV and saquinavir/
SQV) were described to exert a dose-dependent antileishmanial
activity against L. infantum and L. major promastigotes in vitro [10].
Interestingly, we have recently reported the leishmaniacidal
activity of PIs in an experimental cell culture system, in which
we show that nelfinavir (NFV) acts as a powerful in vitro inhibitor of
the intracellular growth of Leishmania in both monocytoid THP-1
cells and human primary monocyte-derived macrophages [11].
Moreover, subcytotoxic concentrations of NFV and ritonavir
(RTV) significantly inhibit the growth of axenic amastigotes in vitro
[11]. Although these previous studies clearly show that HIV-1 PIs
can inhibit the growth of Leishmania parasites, the exact mode(s) of
action of such compounds remains to be established. In
mammalian cancer cell lines, NFV is known to induce apoptotic
death [12]. Interestingly, it was recently demonstrated that a 24 h
treatment with the PI lopinavir (LPV) causes chromatin conden-
sation in L. amazonensis promastigotes, which is suggestive of
apoptosis [13]. However, whether the PI NFV can bring about
similar effects on Leishmania amastigotes remains unknown.
Previous studies have revealed that apoptosis, which is considered
as a tightly regulated form of cell death, plays a dominant role in the
interaction between Leishmania and its host. For example, primed
macrophages were reported to kill intracellular parasites by inducing
apoptosis through a caspase- and cysteine protease-independent
mode [14,15]. Leishmania can undergo apoptosis under in vitro
conditions following exposure to various stimuli such as generation
of reactive oxygen species (ROS), which will eventually lead to
changes in mitochondrial membrane potential, endonuclease
activation and DNA laddering. Together these metabolic processes
will result in nuclear condensation, cell cycle arrest and surface
binding of annexin V to phosphatidylserines. Furthermore, several
reports have suggested that Leishmania can undergo apoptosis by
caspase activation [16,17,18,19]. However no caspase gene has been
identified in the L. major genome sequence database [20]. Recently,
several groups have suggested that a mitochondrial nuclease
homologous to endonuclease G (EndoG) is involved in a caspase-
independent apoptosis in Trypanosoma and Leishmania parasites
[21,22,23]. Moreover, involvement of EndoG in nucleosomal
DNA degradation was also found in sustained endogeneous
oxidative stress [21,22,24]. It is therefore quite obvious that
apoptosis of Leishmania can be induced by distinct pathways
[16,18,19,22], although it is unclear if any of these mechanisms
are involved in the previously reported NFV-mediated antileishma-
nial activity [11].
In the present study, we report that NFV induces apoptosis in
axenically grown Leishmania amastigotes. Moreover, we show that
NFV mediates a caspase-independent apoptosis via an oxidative
stress, which culminates in mitochondrial membrane depolariza-
tion in the protozoan parasite Leishmania. This biochemical event
leads to a release of EndoG from the depolarized mitochondria
resulting ultimately in DNA fragmentation. Together our results
provide the first insights into the cell death mechanisms induced
by NFV in the Leishmania parasite.
Materials and Methods
Chemicals
The HIV-1 PI NFV was obtained from the NIH AIDS
Repository Reagent Program (Germantown, MD). This com-
pound was resuspended to a concentration of 50 mM in dimethyl
sulfoxide (DMSO) for a maximum final concentration in culture of
0.1% DMSO. The benzyloxycarbonyl-Val-Ala-DL-Asp(O-meth-
yl)-fluoromethylketone (z-VAD-fmk) reagent, a caspase inhibitor
with broad specificity, was purchased from Sigma-Aldrich (St.
Louis, MO), was dissolved in DMSO at 20 mM concentration and
stored at 220uC. Aurintricarboxylic acid ammonium salt (ATA,
20 mM, stock solution, Sigma-Aldrich) and N-Acetyl cysteine
(NAC, 0.5 M, stock solution, Sigma-Aldrich) were dissolved in
water and stored at 220uC. Propidium iodide (Sigma-Aldrich) was
also dissolved in water at a final concentration of 1 mg/ml and
stored at 4uC. Miltefosine was from Cayman Chemicals (Ann
Arbor, MI) and stored at 220uC.
Parasite culture and maintenance
Axenically grown amastigotes of L. donovani field strain 9518 (Ld
9518) were maintained at 37uC with 5% CO2 by weekly
subpassages in MAA/20 medium pH (5.6) in 25-cm
2 flasks.
MAA/20 consists of modified medium 199 (Gibco BRL, Carlsbad,
CA) with Hank’s salts, supplemented with 0.5% soybean trypto-
casein (Pasteur Diagnostics, Marne la Coquette, France), 15 mM
D-glucose, 5 mM L-glutamine, 4 mM NaHCO3, 0.023 mM
bovine hemin and 25 mM HEPES at a final pH of 6.5 and
supplemented with 20% of fetal bovine serum (FBS). These axenic
amastigotes show morphological, biochemical and biological
characteristics similar to those of amastigotes isolated in vivo. L.
infantum (MHOM/MA/67/ITMAP-263) promastigotes transfect-
ed with pSPazeoa and pSPazeoaGSH1, hereafter called Li-pSP
and Li-GSH1, were maintained at pH 7.0 and at a temperature of
25uC and cultured in RPMI-1640 medium (Wisent, St.-Bruno,
Quebec) supplemented with 10% FBS, 5 mg/mL hemin, 25 mM
HEPES, 2 mM NaHCO3 and 800 mg/ml of the selective agent
Zeocin (Invivogen, San Diego, CA) in 25-cm
2 flasks. Li-pSP and
Li-GSH1 axenic amastigotes were obtained after several days of
culture by seeding promastigotes in 25-cm
2 flasks containing
MAA/20 medium at a final pH of 5.6 as described above except
for the addition of 800 mg/ml Zeocin.
Selection of NFV-resistant amastigotes
Axenically grown amastigotes of L. donovani Ld 9518 were
subjected to stepwise increasing drug concentrations until
Author Summary
Visceral leishmaniasis is the most severe form of disease
caused by the parasite Leishmania. It is a major concern in
South America, Africa, India and the Middle East.
Additionally, it has now emerged as an important
opportunistic disease in patients coinfected with HIV-1.
This is due, in part, to the increasing overlap between
urban centers and rural areas endemic for Leishmania.
Although more efficient combinatorial antiviral drug
regimens for treating HIV-1 infection have been devel-
oped, the impact of such therapies on HIV-1/Leishmania
coinfection is yet to be explored. In this study, we
investigated the effect of nelfinavir, a well-characterized
anti-HIV-1 drug, on Leishmania. Treating the parasite with
nelfinavir activates events that are hallmarks of pro-
grammed cell death (also called apoptosis). Among these
are oxidative stress, changes in DNA replication and
fragmentation, and release of mitochondrial enzymes.
Furthermore, these events occur without the participation
of caspases, which are classically linked to apoptosis;
however, this atypical apoptosis requires the translocation
of endonuclease G from mitochondria to the cytoplasm.
These findings provide insights for the design of new anti-
parasitic therapies, particularly in the case of Leishmania/
HIV-1 coinfections.
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increase in drug concentration was undertaken only when the
drug-exposed cultures showed a growth rate equivalent to that of
unexposed cultures. Parasites displaying a resistance phenotype
were maintained under a constant drug pressure (i.e. 6.25 and
12.5 mM) throughout our entire experimental procedures. Resis-
tant clones were also stored in 2150uC at various times during
their establishment.
DNA fragmentation assays
Log-phase axenic amastigotes were seeded at a final concen-
tration of 5610
6 parasites/ml and drugs were added to the culture
media at the listed concentrations. Total DNA (i.e. 10 mg) was
extracted at different intervals by the salting out method [25].
Parasites were then pelleted and resuspended in 300 ml of lysis
buffer (i.e. 10 mM Tris-HCl pH 8, 5 mM EDTA, 0.5% SDS,
200 mM NaCl and 100 mg/ml proteinase K) for 45 min at 65uC.
Two volumes of ice-cold ethanol (100%) were added and DNA
was collected by centrifuging at 13,000 rpm for 15 min in a
microfuge. Supernatants were discarded and dried pellets of DNA
were resuspended in 50 ml of 10 mM Tris-HCl pH 8 and 0.1 mM
EDTA, and treated with RNase A (0.3 mg/ml) for 1 h at 37uC.
Qualitative analysis of nuclear DNA fragmentation was performed
by 1% agarose gel electrophoresis. In some studies, untreated or
NFV-treated axenic amastigotes were washed in PBS. Pelleted
cells were permealized in hypotonic lysis buffer (0.1% sodium
citrate and 0.1% Triton X-100) and incubated overnight at 4uC
containing 50 mg/ml propidium iodide and 100 mg/ml RNase.
The fluorescence intensity of propidium iodide was analyzed with
a Coulter EPICS XL flow cytometer (Beckman, Miami, FL) and
FCS express software (version 3).
Measurement of Dym
Change in Dym was measured by Cayman’s JC-1 mitochon-
drial membrane potential assay kit (Cayman Chemical Company,
Ann Arbor, MI). This dye accumulates in the mitochondrial
matrix under the influence of Dym and its monomeric form
increases in unhealthy or apoptotic cells [26]. Ld 9518 amastigotes
were cultured in 24 well plates at a density of 5610
5 cells/well in
400 ml of MAA/20 medium in a CO2 incubator overnight at
37uC. Parasites were then treated with 40 mM NFV for different
time periods afterwhich 40 ml of JC-1 staining solution (prepared
according to the manufacturer’s instructions) was added to each
well. The cells were then incubated at 37uC in a 5% CO2
incubator for 30 min, and transferred to 96-well black culture
plates. Finally, a spectrofluorometer using 485 nm and 535 nm as
excitation and emission wavelengths, respectively, was used to
measure Dym.
Cell fractionation and immunoblotting
Ld 9518 axenic amastigotes (5610
6 cells/ml) were treated with
40 mM of NFV for different time periods before monitoring the
cytoplasmic translocation of EndoG. In some studies, parasites
were first treated with NAC (20 mM) prior to exposure to NFV.
Cell fractionation was carried out using the ApoAlert Cell
fractionation kit (Clontech, Mountain View, CA). After the
separation of cytosolic and mitochondrial fractions, 5 mgo f
protein from each fraction was electrophoresed in different sets
of 12% SDS-PAGE and transferred to nitrocellulose membranes.
Thereafter, membranes were blocked using 5% skimmed milk and
immunoblotted with rabbit polyclonal anti-human EndoG (Santa
Cruz Biotech, Santa Cruz, CA), followed by anti-rabbit HRP-
conjugated antibodies. For loading controls corresponding to
mitochondrial and cytosolic fractions, the same blots were
reprobed with anti-COX IV antibodies provided with the
ApoAlert Cell fractionation kit and anti-human DHFR antibodies
(Santa Cruz Biotech) followed by the appropriate HRP-conjugated
secondary antibodies. The anti-EndoG, anti-COX IV and anti-
DHFR antibodies show cross-reactivity with the corresponding
Leishmania proteins.
Statistical analysis
The statistical significance of the results was defined by
performing a 1-way analysis of variance with Bonferroni’s multiple
comparison tests and unpaired t test. All statistical analyses were
performed using Prism software 3.03. P values of less than 0.05
were considered statistically significant.
Results
NFV induces an apoptosis-like death in Leishmania
Our initial studies were performed with the 9551 field strain of
L. donovani. However, we were unable to obtain axenic amastigotes
from this viscerotropic strain of Leishmania. Therefore, we used the
sodium stibogluconate (SbV)-resistant L. donovani field strain 9518
(Ld 9518) in the majority of experiments described in the present
work, of which we regularly could obtain axenic amastigotes in our
laboratory. It should be noted that this L. donovani field isolate was
previously shown to be sensitive to NFV in promastigote-infected
human primary monocyte-derived macrophages [11].
In order to investigate the mechanism(s) by which NFV affects
Leishmania growth, we analysed the integrity of nuclear DNA of
untreated and NFV-treated Ld 9518 amastigotes by agarose gel
electrophoresis. A combination of ladder and degradation patterns
of nuclear DNA fragments was observed beginning at 24 h of
NFV treatment, although more pronounced degradation of DNA
was achieved after longer treatment (Fig. 1). Miltefosine (MTF)
was used as a positive control in this study, having been already
shown to induce apoptosis in Leishmania [27,28,29]. Therefore, as
expected, a comparable degradation of nuclear DNA fragments
was also observed after a 12 h treatment with MTF, culminating
to complete degradation after 24 h of treatment. DNA of
untreated parasites, or that of parasites treated with the highest
concentration of diluent (i.e. 0.05% DMSO), showed no
fragmentation (data not shown).
To investigate more deeply the effect of NFV on Leishmania,w e
generated NFV-resistant mutants by increasing the drug concen-
tration in several steps, as previously described [30]. Parasites were
continuously maintained under drug pressure and optical density
was measured at every passage. After 7 days of culture, we
observed a 21% and 33% decrease in parasite growth when using
NFV at 6.25 and 12.5 mM, respectively (P,0.001) (Fig. 2A). After
8 consecutive passages, the growth rates of parasites treated with
the two tested concentrations of NFV were similar to the untreated
parasites (Fig. 2B), thus suggesting that we are able to derive
parasites displaying a resistant phenotype.
Next, to further confirm and evaluate the NFV-mediated
induction of apoptosis, we performed an in vitro apoptosis detection
assay by staining the sub-G1 DNA content of both NFV-sensitive
(i.e. wild-type/WT) and -resistant Ld 9518 amastigotes (i.e.
12.5 mM) with propidium iodide. Next, the percentages of
parasites containing sub-G1 DNA (below the G0/G1 peak) were
measured by flow cytometry. After a 24 h treatment with NFV,
the percentage of drug-sensitive amastigotes in the sub-G1 phase
(i.e. M1 region) obtained was 38.7%, compared to 49.5% in the
G1 fraction (i.e. M2 region) (Fig. 3). As expected, a low sub-G1
fraction is detected in untreated parasites (i.e. 8.9%), therefore
confirming that NFV induces DNA fragmentation in axenic
Nelfinavir Mediates Leishmania Apoptosis
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parasites with a sub-G1 content are also less important in both
untreated (i.e. 10.4%) and drug-treated NFV-resistant axenic
amastigotes (i.e. 17.5%). Again, these observations are further
suggesting that NFV causes an apoptosis-like death process in
Leishmania.
NFV induces a caspase-independent death process and
oxidative stress in Leishmania
As apoptosis involves endonuclease-mediated DNA fragmenta-
tion and caspases activate the endonuclease responsible for
cleaving cellular DNA, a pan-caspase inhibitor (i.e. z-VAD-fmk)
was used to investigate if these two pathways are involved in NFV-
induced apoptosis in Leishmania. Pretreatment of the parasites with
z-VAD-fmk (25 mM) did not bring any decrease in the percentage
of sub-G1 DNA content in amastigotes with respect to NFV
treatment, as the percentage of sub-G1 DNA in NFV-treated
parasites, either pre-treated with z-VAD-fmk (57%) or not (54%),
were similar (P.0.05) (Fig. 4). Similar observations were obtained
when using higher concentrations of z-VAD-fmk (i.e. up to
100 mM) (data not shown). Therefore, NFV induces apoptosis in
Leishmania in a caspase-independent manner.
We next examined the role of endonucleases in NFV-mediated
DNA degradation. In this regard, parasites were pretreated with
the endonuclease inhibitor aurin tricarboxylic acid (ATA), prior to
NFV. Treatment of these parasites with both ATA and NFV
exhibited an 18% reduction in sub-G1 DNA content in
comparison to amastigotes only treated with NFV (Fig. 4).
However, statistical analysis showed that this reduction was not
significant (P.0.05).
Finally, we determined whether NFV induces oxidative stress in
Leishmania. To this end, parasites were treated with the antioxidant
N-acetyl-cysteine (NAC) prior to NFV. Our results show that NAC
pre-treatment caused a 80% reduction in the sub-G1 DNA
induced by NFV (Fig. 4), a statistically significant decrease when
compared to the amount of sub-G1 DNA in NFV-treated parasites
(P,0.001). Pre-treatment with NAC would therefore inhibit the
Figure 1. NFV induces degradation of genomic DNA isolated from L. donovani amastigotes. Genomic DNA was isolated from Ld 9518
amastigotes which have been treated with NFV or MTF (25 mM in both instances) for the indicated time periods and was resolved on 1% agarose gel.
M corresponds to 1 Kb DNA ladder.
doi:10.1371/journal.pntd.0000642.g001
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initial seeding. (B) Growth curve was determined after 8 passages. The growth of parasites was followed by measuring the optical density (OD) at
600 nm at the listed days.
doi:10.1371/journal.pntd.0000642.g002
Figure 3. NFV induces an increase in the sub-G1 DNA-containing population. The DNA content degradation profiles of drug-sensitive and
NFV-resistant axenic amastigotes (i.e. usually maintained under a constant drug pressure of 12.5 mM), which were either left untreated or treated with
NFV (10 mM), were assessed by flow cytometry after cell permeabilisation and PI staining. DNA fragmentation was quantified by measuring the cell
population in the sub-G1 DNA region indicated by M1 and G1 DNA peak indicated by M2. The data shown are representative of three independent
experiments.
doi:10.1371/journal.pntd.0000642.g003
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from oxidative stress.
NFV leads to a loss of mitochondrial potential and
translocation of EndoG
A characteristic feature of apoptosis is the loss of mitochondrial
potential (ym), which induces ROS formation and oxidative stress
inside the parasite [22]. Using a dye (JC-1) sensitive to the loss in
Dym, we monitored the mitochondrial membrane potential by
spectrofluorometry. As shown in Fig. 5A, fluorescence increased
with time upon NFV treatment. We observed a plateau in
fluorescence intensity, corresponding to a complete loss of Dym,
after 2 h following initial contact with NFV.
EndoG is involved in caspase-independent apoptosis and is a
mitochondrial resident protein which cleaves the nuclear DNA
[21,31,32], after its release from depolarized mitochondria
through transition pores. Since our previous results suggested that
NFV induces a loss of mitochondrial potential, we set out to
determine if NFV also caused mitochondrial release of EndoG.
Mitochondrial and cytosolic extracts prepared from both untreat-
ed and NFV-treated parasites were separated on SDS-PAGE,
transferred to membranes and immunoblotted with anti-EndoG
antibodies. The gradual translocation of EndoG to the cytoplasm
was observed with time after NFV treatment (Fig. 5B). No
variation in band intensities corresponding to COX IV (for the
mitochondrial extracts) and DHFR-TS (for the cytosolic extracts)
were observed, and were used as loading controls. Furthermore,
this cytoplasmic translocation of EndoG was inhibited by the
addition of NAC (Fig. 6).
Expression of GSH1 protects amastigotes against NFV-
induced cell death
Glutathione (GSH) has been shown to protect cells from
oxidative stress, as well as from the effect of several drugs. In order
to further our understanding of the possible effect of NFV-induced
ROS, we tested L. infantum axenic amastigotes transfected with the
empty control vector pSPazeoa (called Li-pSP) or a pSPazeoa
vector containing the gsh1 gene (called Li-GSH1). The gsh1 gene
Figure 4. NFV generates an oxidative stress-mediated caspase-independent death process. Drug-sensitive axenic amastigotes were
either left untreated or treated for 2 h with the indicated compounds, i.e. caspase inhibitor z-VAD-fmk (25 mM), Endo-G inhibitor ATA (50 mM) and
antioxidant NAC (20 mM). Next, parasites were subjected to a treatment for 24 h with NFV (40 mM) or the diluent (i.e. DMSO). Percentage of apoptotic
cells was measured by staining with propidium iodide as described in Materials and Methods. Data are expressed as mean 6 SD of three independent
experiments.
doi:10.1371/journal.pntd.0000642.g004
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GCS), the rate limiting enzyme of GSH biosynthesis in Leishmania
[33,34]. When Li-GSH1 parasites were subjected to a 12 h
treatment with NFV, we observed a significant decrease (57%) in
sub-G1 DNA content, when compared to NFV-treated control Li-
pSP parasites (Fig. 7). This confirmed our previous observations
that parasites generate ROS after exposure to NFV, and
overexpression of GSH1 inhibits the effects of ROS in these cells.
Discussion
In recent years, the number of worldwide reported cases of
Leishmania/HIV-1 coinfections has been increasing steadily given
the growing spread of the AIDS pandemic to smaller urban
centers and more outlying urban and rural areas where Leishmania
infections are more prevalent [1,35]. Besides this expanding
geographical overlap, these two diseases are changing their
clinical, epidemiological and therapeutic aspects as they both
impact on each other’s development. For instance, in Africa and
India, where L. donovani/HIV-1 coinfections are emerging, there
are high rates of VL relapse and mortality [1,36,37]. Furthermore,
the use of contaminated syringes by intravenous drug users has
now also been identified as a way of transmission of Leishmania,a s
well as for HIV-1, particularly in Southern Europe and the
Mediterranean basin [38]. In addition to these factors, Leishmania
and HIV-1 act in a concerted manner in the coinfected individual,
Figure 5. Loss of mitochondrial potential and translocation of EndoG in NFV-treated L. donovani amastigotes. (A) L. donovani axenic
amastigotes were exposed to the diluent or NFV (40 mM) for the indicated time periods. Mitochondrial membrane potential (Dym) was assessed
through the use of the JC-1 Mitochondrial Membrane Potential Detection Kit. Data are expressed as mean 6 SD of three independent experiments.
(B) Western blot analysis of the mitochondrial and cytosolic fractions obtained from NFV-treated amastigotes at different intervals. Anti-EndoG
immunoblots of cytosolic and mitochondrial fractions are shown, along with the loading controls for mitochondria (i.e. COX IV) and cytosol (i.e. DHFR-
TS), respectively.
doi:10.1371/journal.pntd.0000642.g005
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accelerates the progression toward AIDS, whereas HIV-1 can
reinitiate or worsen Leishmania-related symptoms [2,4,5].
Improper diagnosis and the misuse of leishmaniacidal com-
pounds have also complicated the treatment of Leishmania/HIV-1
coinfected individuals, and have contributed to the rise in the
number of coinfected cases. For example, our group has previously
reported that SbV, a widely used drug in the treatment against
leishmaniasis, can accelerate HIV-1 replication under in vitro
conditions [39]. These findings, combined with the fact that little is
known on the effect of drugs designed specifically against HIV-1 or
Leishmania in coinfected individuals, warrant further investigation
into the impact of these compounds and their action on the
opposite microbe.
In a recent paper, our group reported that drugs designed
against the protease of HIV-1 markedly reduced the intracellular
survival of L. infantum and L. donovani in both the macrophage cell
line THP-1 and more physiologically relevant human monocyte-
derived macrophages [11]. We also observed that, although we did
not find any toxic effect of these drugs on promastigotes, the HIV-
1 PIs NFV and RTV were effective against Leishmania axenic
amastigotes at subcytotoxic levels. Given the long term potential of
such findings for the treatment of Leishmania/HIV-1 coinfections,
we further investigated by which mechanism HIV-1 PIs,
specifically NFV, exert their effect on Leishmania amastigotes in
culture. Besides being in the developmental stage of the parasite
which is most affected by these drugs, it was also relevant to pursue
such a study since amastigotes are the form of Leishmania usually
found in humans. However, it should be pointed out that although
the NFV concentrations used in this study were much stronger
than those found in plasma of treated patients [40], it could be
argued that, due to the accumulation of drug in macrophages [41],
these higher concentrations may be relevant when used directly in
media cultured parasites in order to compensate for this effect.
We first observed that nuclear DNA from NFV-treated axenic
L. donovani amastigotes formed a long smear when resolved using
agarose gel electrophoresis. Although not a classical ladder pattern
associated with apoptosis, this degraded form of DNA is not
uncommon in apoptotic L. donovani, as has been previously
reported [18]. Similar patterns of DNA degradation have been
observed in Leishmania parasites treated, among others, with MTF,
a relatively recently developed antileishmanial drug which we have
Figure 6. Cytosolic translocation of EndoG in NFV-treated L. donovani amastigotes is inhibited by addition of antioxidant. (A) L.
donovani axenic amastigotes were exposed to NFV (40 mM) for 0 or 8 h with or without pre-treatment with NAC (20 mM). Western blot analysis of the
cytosolic fractions obtained from the amastigotes was then performed using anti-EndoG (upper panel) and DHFR-TS (lower panel, as loading control).
Densitometric analysis of blots from three of these experiments are shown in (B).
doi:10.1371/journal.pntd.0000642.g006
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established drugs are known to induce this effect on Leishmania,
including pentavalant antimony, pentamidine, and amphotericin
B [42]. However, our observations are of potential long term
interest in the case of HIV-1/Leishmania coinfections, since NFV
acts on both HIV-1 and the amastigote parasites in vitro.
The mechanisms involved in Leishmania apoptosis are not as well
understood as in mammalian cells, but have been the object of
several investigations in the recent past years [18,21,22,43].
Indeed, some similarities can be made between both organisms.
First, in both cases, mitochondria have been identified as major
regulators of the apoptotic process, and permeabilization of the
mitochondrial membrane by oxidative stress or other stresses leads
to the release of proapoptotic enzymes in the cytosol. Relocation of
cytochrome C and activation of cellular proteases act as
irreversible commitments to the apoptotic death pathway.
However, given that the equivalents of mammalian caspases have
yet to be identified in Leishmania, at least part of the apoptotic
machinery used by the parasite is caspase-independent. In this
regard, we observed no effect of the caspase inhibitor z-VAD-fmk
in NFV-induced apoptosis in Leishmania, suggesting that the
mechanism(s) involved in this case is caspase-independent.
Interestingly, Verma and colleagues reported that MTF activates
caspase 3-like proteases in arsenite-resistant L. donovani promasti-
gotes, and that their action was sensitive to the CED3/CPP32-
specific inhibitor DEVD-fmk [44]. The recent identification of
metacaspases in Trypanosoma brucei and L. major may further shed
light on the specific pathways involved in Leishmania apoptotic cell
death in response to drug treatments [43]. However, although
metacaspases and caspases may be structurally similar, the
catalytic activity of metacaspases in Leishmania is quite different
from that of caspases, suggesting that different apoptotic pathways
are involved.
Recently, several papers have proposed a role for EndoG, a
mitochondrial protease, in chromatin degradation of trypanoso-
matids such as Leishmania and Trypanosoma. Gannavaram and co-
workers showed that, when transfected with L. major EndoG, over-
expressing L. donovani promastigotes exhibited increased sensitivity
to oxidative stresses and engaged in translocation of EndoG to the
cytosol [21]. Furthermore, Rico and colleagues demonstrated that
L. infantum EndoG reacted similarly when these parasites are faced
with apoptotic stimuli [23]. Finally, BoseDasgupta et al. further
investigated the mechanisms of apoptosis in L. donovani promas-
tigotes induced by the flavone baicalein, a topoisomerase-DNA
complex stabilizer [22]. The authors found that, once released,
EndoG formed a complex with flap endonuclease-1 (FEN-1), an
enzyme involved in DNA repair, and, independently, with a Tat-
D-like nuclease, in order to degrade DNA and possibly promote
apoptosis. It is therefore possible that this is also the case in NFV-
treated amastigotes, given that we also observed ATA-sensitive
apoptosis and EndoG translocation to the cytosol. The same
authors have also reported that the EndoG release from
mitochondria is calcium-dependent and sensitive to the antioxi-
dant NAC or the calcium chelator BAPTA-AM [22]. In this
regard, we found that L. donovani axenic amastigotes responded in
a similar, NAC-sensitive manner to NFV. Our finding that c-GCS
and GSH overexpression in L. infantum amastigotes, protecting the
parasites from oxidative stress, counteracts the pro-apoptotic
Figure 7. GSH1 overexpression suppresses NFV-induced cell death in parasites. Stably transfected L. infantum strains carrying either the
empty control vector Pspazeoa (i.e. Li-pSP) or the GSH1-encoding vector PspazeoaGSH1 were exposed to NFV (40 mM) for 24 h. Cell death was
measured in terms of DNA degradation. Light gray bars refer to untreated parasites, whereas black bars relate to NFV-treated parasites (n=3) (***,
P,0.001).
doi:10.1371/journal.pntd.0000642.g007
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oxidative stress. It is therefore possible that very similar apoptotic
pathways are activated in Leishmania promastigotes treated with
baicalein, and amastigotes treated with NFV. However, additional
experiments are warranted to clearly determine if such is the case.
With the expanding overlap between HIV-1 infection and
leishmaniases in the world, it is now critical to better understand
the multifaceted effects of antiviral and antiparasitic drugs in the
case of HIV-1/Leishmania coinfected individuals. In this report, we
determined how L. donovani amastigotes react to NFV, an HIV-1
PI, and that these processes lead to apoptotic death through a
caspase-independent mechanism. Another group has recently
described that HIV-1 PIs also affect L. amazonensis proliferation
and infection of murine macrophages, and observed chromatin
condensation in parasites suggesting apoptosis [13]. Further
investigation will determine if such is a general reaction of
trypanoplasmids to HIV-1 PIs, hopefully leading to a better
understanding of these agents and possibly future therapeutic use
in coinfected individuals. However, one must note that HIV-1 PIs
may also exert toxicity in humans by inducing a mitochondrial loss
of potential and apoptosis (for example, of T cells) [45,46].
Therefore, careful evaluation of the benefits and pitfalls of such
therapies must be evaluated when designing future chemothera-
peutic strategies to test NFV as a potential possible antileishmanial
agent as well as possibly in Leishmania/HIV-1 coinfections.
Author Contributions
Conceived and designed the experiments: Pranav Kumar, Robert Lodge,
Michel Ouellet, Michel J. Tremblay. Performed the experiments: Pranav
Kumar, Nathalie Trudel. Analyzed the data: Pranav Kumar, Robert
Lodge, Michel J. Tremblay. Contributed reagents/materials/analysis tools:
Marc Ouellette. Wrote the paper: Pranav Kumar, Robert Lodge, Nathalie
Trudel, Michel Ouellet, Marc Ouellette, Michel J. Tremblay.
References
1. Alvar J, Aparicio P, Aseffa A, Den Boer M, Canavate C, et al. (2008) The
relationship between leishmaniasis and AIDS: the second 10 years. Clin
Microbiol Rev 21: 334–359.
2. Dedet JP, Pratlong F (2000) Leishmania, Trypanosoma and monoxenous
trypanosomatids as emerging opportunistic agents. J Eukaryot Microbiol 47:
37–39.
3. Cruz I, Nieto J, Moreno J, Canavate C, Desjeux P, et al. (2006) Leishmania/HIV
co-infections in the second decade. Indian J Med Res 123: 357–388.
4. Zhao C, Papadopoulou B, Tremblay MJ (2004) Leishmania infantum promotes
replication of HIV type 1 in human lymphoid tissue cultured ex vivo by inducing
secretion of the proinflammatory cytokines TNF-alpha and IL-1 alpha.
J Immunol 172: 3086–3093.
5. Zhao C, Thibault S, Messier N, Ouellette M, Papadopoulou B, et al. (2006) In
primary human monocyte-derived macrophages exposed to Human immuno-
deficiency virus type 1, does the increased intracellular growth of Leishmania
infantum rely on its enhanced uptake? J Gen Virol 87: 1295–1302.
6. Deeks SG, Smith M, Holodniy M, Kahn JO (1997) HIV-1 protease inhibitors. A
review for clinicians. JAMA 277: 145–153.
7. de la Rosa R, Pineda JA, Delgado J, Macias J, Morillas F, et al. (2001) Influence
of highly active antiretroviral therapy on the outcome of subclinical visceral
leishmaniasis in human immunodeficiency virus-infected patients. Clin Infect
Dis 32: 633–635.
8. Lopez-Velez R (2003) The impact of highly active antiretroviral therapy
(HAART) on visceral leishmaniasis in Spanish patients who are co-infected with
HIV. Ann Trop Med Parasitol 97 Suppl 1: 143–147.
9. Rosenthal E, Tempesta S, Del Giudice P, Marty P, Desjeux P, et al. (2001)
Declining incidence of visceral leishmaniasis in HIV-infected individuals in the
era of highly active antiretroviral therapy. AIDS 15: 1184–1185.
10. Savoia D, Allice T, Tovo PA (2005) Antileishmanial activity of HIV protease
inhibitors. Int J Antimicrob Agents 26: 92–94.
11. Trudel N, Garg R, Messier N, Sundar S, Ouellette M, et al. (2008) Intracellular
survival of Leishmania species that cause visceral leishmaniasis is significantly
reduced by HIV-1 protease inhibitors. J Infect Dis 198: 1292–1299.
12. Gills JJ, Lopiccolo J, Tsurutani J, Shoemaker RH, Best CJ, et al. (2007)
Nelfinavir, A lead HIV protease inhibitor, is a broad-spectrum, anticancer agent
that induces endoplasmic reticulum stress, autophagy, and apoptosis in vitro and
in vivo. Clin Cancer Res 13: 5183–5194.
13. Santos LO, Marinho FA, Altoe EF, Vitorio BS, Alves CR, et al. (2009) HIV
aspartyl peptidase inhibitors interfere with cellular proliferation, ultrastructure
and macrophage infection of Leishmania amazonensis. PLoS ONE 4: e4918.
14. Holzmuller P, Sereno D, Cavaleyra M, Mangot I, Daulouede S, et al. (2002)
Nitric oxide-mediated proteasome-dependent oligonucleosomal DNA fragmen-
tation in Leishmania amazonensis amastigotes. Infect Immun 70: 3727–3735.
15. Zangger H, Mottram JC, Fasel N (2002) Cell death in Leishmania induced by
stress and differentiation: programmed cell death or necrosis? Cell Death Differ
9: 1126–1139.
16. Lee N, Bertholet S, Debrabant A, Muller J, Duncan R, et al. (2002)
Programmed cell death in the unicellular protozoan parasite Leishmania. Cell
Death Differ 9: 53–64.
17. Arnoult D, Akarid K, Grodet A, Petit PX, Estaquier J, et al. (2002) On the
evolution of programmed cell death: apoptosis of the unicellular eukaryote
Leishmania major involves cysteine proteinase activation and mitochondrion
permeabilization. Cell Death Differ 9: 65–81.
18. Das M, Mukherjee SB, Shaha C (2001) Hydrogen peroxide induces apoptosis-
like death in Leishmania donovani promastigotes. J Cell Sci 114: 2461–2469.
19. Sen N, Banerjee B, Das BB, Ganguly A, Sen T, et al. (2007) Apoptosis is induced
in leishmanial cells by a novel protein kinase inhibitor withaferin A and is
facilitated by apoptotic topoisomerase I-DNA complex. Cell Death Differ 14:
358–367.
20. Ivens AC, Peacock CS, Worthey EA, Murphy L, Aggarwal G, et al. (2005) The
genome of the kinetoplastid parasite, Leishmania major. Science 309: 436–442.
21. Gannavaram S, Vedvyas C, Debrabant A (2008) Conservation of the pro-
apoptotic nuclease activity of endonuclease G in unicellular trypanosomatid
parasites. J Cell Sci 121: 99–109.
22. BoseDasgupta S, Das BB, Sengupta S, Ganguly A, Roy A, et al. (2008) The
caspase-independent algorithm of programmed cell death in Leishmania induced
by baicalein: the role of LdEndoG, LdFEN-1 and LdTatD as a DNA
‘degradesome’. Cell Death Differ 15: 1629–1640.
23. Rico E, Alzate JF, Arias AA, Moreno D, Clos J, et al. (2009) Leishmania infantum
expresses a mitochondrial nuclease homologous to EndoG that migrates to the
nucleus in response to an apoptotic stimulus. Mol Biochem Parasitol 163: 28–38.
24. Ishihara Y, Shimamoto N (2006) Involvement of endonuclease G in nucleosomal
DNA fragmentation under sustained endogenous oxidative stress. J Biol Chem
281: 6726–6733.
25. Rotureau B, Gego A, Carme B (2005) Trypanosomatid protozoa: a simplified
DNA isolation procedure. Exp Parasitol 111: 207–209.
26. Salvioli S, Ardizzoni A, Franceschi C, Cossarizza A (1997) JC-1, but not
DiOC6(3) or rhodamine 123, is a reliable fluorescent probe to assess delta psi
changes in intact cells: implications for studies on mitochondrial functionality
during apoptosis. FEBS Lett 411: 77–82.
27. Seifert K, Matu S, Javier Perez-Victoria F, Castanys S, Gamarro F, et al. (2003)
Characterisation of Leishmania donovani promastigotes resistant to hexadecylpho-
sphocholine (miltefosine). Int J Antimicrob Agents 22: 380–387.
28. Verma NK, Dey CS (2004) Possible mechanism of miltefosine-mediated death of
Leishmania donovani. Antimicrob Agents Chemother 48: 3010–3015.
29. Vergnes B, Gourbal B, Girard I, Sundar S, Drummelsmith J, et al. (2007) A
proteomics screen implicates HSP83 and a small kinetoplastid calpain-related
protein in drug resistance in Leishmania donovani clinical field isolates by
modulating drug-induced programmed cell death. Mol Cell Proteomics 6:
88–101.
30. Sereno D, Cavaleyra M, Zemzoumi K, Maquaire S, Ouaissi A, et al. (1998)
Axenically grown amastigotes of Leishmania infantum used as an in vitro model to
investigate the pentavalent antimony mode of action. Antimicrob Agents
Chemother 42: 3097–3102.
31. Li LY, Luo X, Wang X (2001) Endonuclease G is an apoptotic DNase when
released from mitochondria. Nature 412: 95–99.
32. van Loo G, Schotte P, van Gurp M, Demol H, Hoorelbeke B, et al. (2001)
Endonuclease G: a mitochondrial protein released in apoptosis and involved in
caspase-independent DNA degradation. Cell Death Differ 8: 1136–1142.
33. Meister A, Anderson ME (1983) Glutathione. Annu Rev Biochem 52: 711–760.
34. Grondin K, Haimeur A, Mukhopadhyay R, Rosen BP, Ouellette M (1997) Co-
amplification of the gamma-glutamylcysteine synthetase gene gsh1 and of the
ABC transporter gene pgpA in arsenite-resistant Leishmania tarentolae. EMBO J 16:
3057–3065.
35. Desjeux P, Alvar J (2003) Leishmania/HIV co-infections: epidemiology in Europe.
Ann Trop Med Parasitol 97 Suppl 1: 3–15.
36. ter Horst R, Collin SM, Ritmeijer K, Bogale A, Davidson RN (2008)
Concordant HIV infection and visceral leishmaniasis in Ethiopia: the influence
of antiretroviral treatment and other factors on outcome. Clin Infect Dis 46:
1702–1709.
37. den Boer ML, Alvar J, Davidson RN, Ritmeijer K, Balasegaram M (2009)
Developments in the treatment of visceral leishmaniasis. Expert Opin Emerg
Drugs 14: 395–410.
38. Molina R, Gradoni L, Alvar J (2003) HIV and the transmission of Leishmania.
Ann Trop Med Parasitol 97 Suppl 1: 29–45.
Nelfinavir Mediates Leishmania Apoptosis
www.plosntds.org 10 March 2010 | Volume 4 | Issue 3 | e64239. Barat C, Zhao C, Ouellette M, Tremblay MJ (2007) HIV-1 replication is
stimulated by sodium stibogluconate, the therapeutic mainstay in the treatment
of leishmaniasis. J Infect Dis 195: 236–245.
40. Goujard C, Legrand M, Panhard X, Diquet B, Duval X, et al. (2005) High
variability of indinavir and nelfinavir pharmacokinetics in HIV-infected patients
with a sustained virological response on highly active antiretroviral therapy. Clin
Pharmacokinet 44: 1267–1278.
41. Jones K, Hoggard PG, Sales SD, Khoo S, Davey R, et al. (2001) Differences in
the intracellular accumulation of HIV protease inhibitors in vitro and the effect
of active transport. AIDS 15: 675–681.
42. Shaha C (2006) Apoptosis in Leishmania species & its relevance to disease
pathogenesis. Indian J Med Res 123: 233–244.
43. Lee N, Gannavaram S, Selvapandiyan A, Debrabant A (2007) Characterization
of metacaspases with trypsin-like activity and their putative role in programmed
cell death in the protozoan parasite Leishmania. Eukaryot Cell 6: 1745–1757.
44. Verma NK, Singh G, Dey CS (2007) Miltefosine induces apoptosis in arsenite-
resistant Leishmania donovani promastigotes through mitochondrial dysfunction.
Exp Parasitol 116: 1–13.
45. Estaquier J, Lelievre JD, Petit F, Brunner T, Moutouh-De Parseval L, et al.
(2002) Effects of antiretroviral drugs on human immunodeficiency virus type
1-induced CD4(+) T-cell death. J Virol 76: 5966–5973.
46. Petit F, Fromenty B, Owen A, Estaquier J (2005) Mitochondria are sensors for
HIV drugs. Trends Pharmacol Sci 26: 258–264.
Nelfinavir Mediates Leishmania Apoptosis
www.plosntds.org 11 March 2010 | Volume 4 | Issue 3 | e642